{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:56:09Z","timestamp":1790636169537,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"DOI":"10.1007\/s11427-026-3389-1","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:30:23Z","timestamp":1790573423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SYVN1-mediated succinate accumulation exacerbates heart failure"],"prefix":"10.1007","author":[{"given":"Hongtu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"3389_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12964-014-0078-2","volume":"12","author":"CJ Aguiar","year":"2014","unstructured":"Aguiar, C.J., Rocha-Franco, J.A., Sousa, P.A., Santos, A.K., Ladeira, M., Rocha-Resende, C., Ladeira, L.O., Resende, R.R., Botoni, F.A., Barrouin Melo, M., et al. (2014). Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun Signal 12, 78.","journal-title":"Cell Commun Signal"},{"key":"3389_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker, S.D., Butler, J., Filippatos, G., Ferreira, J.P., Bocchi, E., B\u00f6hm, M., Brunner-La Rocca, H.P., Choi, D.J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021). Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385, 1451\u20131461.","journal-title":"N Engl J Med"},{"key":"3389_CR3","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/s41591-022-02041-5","volume":"28","author":"SD Anker","year":"2022","unstructured":"Anker, S.D., Butler, J., Usman, M.S., Filippatos, G., Ferreira, J.P., Bocchi, E., Bohm, M., Rocca, H.P.B.L., Choi, D.J., Chopra, V., et al. (2022). Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-preserved. Nat Med 28, 2512\u20132520.","journal-title":"Nat Med"},{"key":"3389_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-025-09097-6","volume":"643","author":"A Chaves-Perez","year":"2025","unstructured":"Chaves-Perez, A., Millman, S.E., Janaki-Raman, S., Ho, Y.J., Hinterleitner, C., Barthet, V.J.A., MorrisIV, J.P., Barriga, F.M., Reyes, J., Kyaw, A., et al. (2025). Metabolic adaptations direct cell fate during tissue regeneration. Nature 643, 468\u2013477.","journal-title":"Nature"},{"key":"3389_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s11658-024-00634-1","volume":"29","author":"Y Chen","year":"2024","unstructured":"Chen, Y., He, W., Qiu, J., Luo, Y., Jiang, C., Zhao, F., Wei, H., Meng, J., Long, T., Zhang, X., et al. (2024). Pterostilbene improves neurological dysfunction and neuroinflammation after ischaemic stroke via HDAC3\/Nrf1-mediated microglial activation. Cell Mol Biol Lett 29, 114.","journal-title":"Cell Mol Biol Lett"},{"key":"3389_CR6","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/eurheartj\/ehab605","volume":"42","author":"H Cui","year":"2021","unstructured":"Cui, H., Chen, Y., Li, K., Zhan, R., Zhao, M., Xu, Y., Lin, Z., Fu, Y., He, Q., Tang, P.C., et al. (2021a). Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur Heart J 42, 4373\u20134385.","journal-title":"Eur Heart J"},{"key":"3389_CR7","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1038\/s41467-021-25653-w","volume":"12","author":"M Cui","year":"2021","unstructured":"Cui, M., Atmanli, A., Morales, M.G., Tan, W., Chen, K., Xiao, X., Xu, L., Liu, N., Bassel-Duby, R., and Olson, E.N. (2021b). Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance. Nat Commun 12, 5270.","journal-title":"Nat Commun"},{"key":"3389_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ejhf.2861","volume":"25","author":"G Filippatos","year":"2023","unstructured":"Filippatos, G., Farmakis, D., Butler, J., Zannad, F., Ferreira, J.P., Ofstad, A.P., Iwata, T., Brueckmann, M., Pocock, S.J., Packer, M., et al. (2023). Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation. Eur J Heart Fail 25, 970\u2013977.","journal-title":"Eur J Heart Fail"},{"key":"3389_CR9","doi-asserted-by":"publisher","first-page":"e012794","DOI":"10.1161\/CIRCHEARTFAILURE.125.012794","volume":"18","author":"A Hacil","year":"2025","unstructured":"Hacil, A., Antakly Hanon, Y., Lacour, A., David, J.P., Khalifa, T., Piccoli, M., Clemencin, A., Assayag, P., Vidal, J.S., and Hanon, O. (2025). Efficacy and safety of SGLT2 inhibitors in heart failure: observational evidence in geriatric patients\u2014AGING-HF. Circ Heart Fail 18, e012794.","journal-title":"Circ Heart Fail"},{"key":"3389_CR10","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P.A., Bozkurt, B., Aguilar, D., Allen, L.A., Byun, J.J., Colvin, M.M., Deswal, A., Drazner, M.H., Dunlay, S.M., Evers, L.R., et al. (2022). 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 145, e895\u2013e1032.","journal-title":"Circulation"},{"key":"3389_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/cac2.12192","volume":"41","author":"F Ji","year":"2021","unstructured":"Ji, F., Zhou, M., Sun, Z., Jiang, Z., Zhu, H., Xie, Z., Ouyang, X., Zhang, L., and Li, L. (2021). Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis. Cancer Commun 41, 1007\u20131023.","journal-title":"Cancer Commun"},{"key":"3389_CR12","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.119.042791","volume":"140","author":"D Kula-Alwar","year":"2019","unstructured":"Kula-Alwar, D., Prag, H.A., and Krieg, T. (2019). Targeting succinate metabolism in ischemia\/reperfusion injury. Circulation 140, 1968\u20131970.","journal-title":"Circulation"},{"key":"3389_CR13","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.1038\/s41467-025-66368-6","volume":"16","author":"H Lei","year":"2025","unstructured":"Lei, H., Zhao, T., Zhang, J., Long, Y., Chen, Y., Zhu, Y., Meng, Y., Tang, Y., Liu, X., Sun, J., et al. (2025). NRF1-mediated innate immune response drives inflammaging. Nat Commun 16, 11367.","journal-title":"Nat Commun"},{"key":"3389_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-023-01015-z","volume":"118","author":"W Li","year":"2023","unstructured":"Li, W., Quan, L., Peng, K., Wang, Y., Wang, X., Chen, Q., Cheng, H., and Ma, Q. (2023). Succinate dehydrogenase is essential for epigenetic and metabolic homeostasis in hearts. Basic Res Cardiol 118, 45.","journal-title":"Basic Res Cardiol"},{"key":"3389_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li, Y., Chen, B., Yang, X., Zhang, C., Jiao, Y., Li, P., Liu, Y., Li, Z., Qiao, B., Bond Lau, W., et al. (2019). S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation 140, 751\u2013764.","journal-title":"Circulation"},{"key":"3389_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G.D., Karwi, Q.G., Tian, R., Wende, A.R., and Abel, E.D. (2021). Cardiac energy metabolism in heart failure. Circ Res 128, 1487\u20131513.","journal-title":"Circ Res"},{"key":"3389_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.06.004","volume":"182","author":"Z Meng","year":"2023","unstructured":"Meng, Z., Liang, B., Wu, Y., Liu, C., Wang, H., Du, Y., Gan, L., Gao, E., Lau, W.B., Christopher, T.A., et al. (2023). Hypoadiponectinemia-induced upregulation of microRNA449b downregulating Nrf-1 aggravates cardiac ischemia-reperfusion injury in diabetic mice. J Mol Cell Cardiol 182, 1\u201314.","journal-title":"J Mol Cell Cardiol"},{"key":"3389_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M., and Sadoshima, J. (2018). Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15, 387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"3389_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbrc.2016.09.147","volume":"479","author":"A Omede","year":"2016","unstructured":"Omede, A., Zi, M., Prehar, S., Maqsood, A., Stafford, N., Mamas, M., Cartwright, E., and Oceandy, D. (2016). The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice. Biochem Biophys Res Commun 479, 708\u2013714.","journal-title":"Biochem Biophys Res Commun"},{"key":"3389_CR20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer, M., Anker, S.D., Butler, J., Filippatos, G., Pocock, S.J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383, 1413\u20131424.","journal-title":"N Engl J Med"},{"key":"3389_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/CIRCRESAHA.121.320717","volume":"131","author":"HA Prag","year":"2022","unstructured":"Prag, H.A., Aksentijevic, D., Dannhorn, A., Giles, A.V., Mulvey, J.F., Sauchanka, O., Du, L., Bates, G., Reinhold, J., Kula-Alwar, D., et al. (2022). Ischemia-selective cardioprotection by malonate for ischemia\/reperfusion injury. Circ Res 131, 528\u2013541.","journal-title":"Circ Res"},{"key":"3389_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-020-01040-5","volume":"19","author":"J Sabatino","year":"2020","unstructured":"Sabatino, J., De Rosa, S., Tamme, L., Iaconetti, C., Sorrentino, S., Polimeni, A., Mignogna, C., Amorosi, A., Spaccarotella, C., Yasuda, M., et al. (2020). Empagliflozin prevents doxorubicin-induced myocardial dysfunction. Cardiovasc Diabetol 19, 66.","journal-title":"Cardiovasc Diabetol"},{"key":"3389_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41467-024-55557-4","volume":"16","author":"P She","year":"2025","unstructured":"She, P., Gao, B., Li, D., Wu, C., Zhu, X., He, Y., Mo, F., Qi, Y., Jin, D., Chen, Y., et al. (2025). The transcriptional repressor HEY2 regulates mitochondrial oxidative respiration to maintain cardiac homeostasis. Nat Commun 16, 232.","journal-title":"Nat Commun"},{"key":"3389_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-022-04553-x","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi, Y., Yang, Y., Xu, W., Shi, D., Xu, W., Fu, X., Lv, Q., Xia, J., and Shi, F. (2022). E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis. Cell Death Dis 13, 106.","journal-title":"Cell Death Dis"},{"key":"3389_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11427-024-2656-6","volume":"68","author":"WT Sun","year":"2025","unstructured":"Sun, W.T., Du, J.Y., Wang, J., Wang, Y.L., and Dong, E.D. (2025). Potential preservative mechanisms of cardiac rehabilitation pathways on endothelial function in coronary heart disease. Sci China Life Sci 68, 158\u2013175.","journal-title":"Sci China Life Sci"},{"key":"3389_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors, A.A., Angermann, C.E., Teerlink, J.R., Collins, S.P., Kosiborod, M., Biegus, J., Ferreira, J.P., Nassif, M.E., Psotka, M.A., Tromp, J., et al. (2022). The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med 28, 568\u2013574.","journal-title":"Nat Med"},{"key":"3389_CR27","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1038\/s41467-022-31548-1","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang, X., Zhang, X., Cao, K., Zeng, M., Fu, X., Zheng, A., Zhang, F., Gao, F., Zou, X., Li, H., et al. (2022). Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy. Nat Commun 13, 3947.","journal-title":"Nat Commun"},{"key":"3389_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s42003-025-09337-5","volume":"9","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Zhang, Z., Ping, Z., Yang, S., Li, Y., Jiang, T., Zheng, X., Zhang, Q., Liu, Z., Zhang, X., et al. (2025). Succinate-driven PKM2 succinylation and dimerization accelerates age-associated cardiac fibrosis. Commun Biol 9, 633.","journal-title":"Commun Biol"},{"key":"3389_CR29","doi-asserted-by":"publisher","first-page":"e98942","DOI":"10.15252\/embj.201898942","volume":"37","author":"J Wei","year":"2018","unstructured":"Wei, J., Chen, L., Li, F., Yuan, Y., Wang, Y., Xia, W., Zhang, Y., Xu, Y., Yang, Z., Gao, B., et al. (2018). HRD1-ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination. EMBO J 37, e98942.","journal-title":"EMBO J"},{"key":"3389_CR30","doi-asserted-by":"publisher","first-page":"114780","DOI":"10.1016\/j.celrep.2024.114780","volume":"43","author":"J Yan","year":"2024","unstructured":"Yan, J., Zhang, X., Wang, H., Jia, X., Wang, R., Wu, S., Zhu, Z.J., Tan, M., and Horng, T. (2024). Macrophage NRF1 promotes mitochondrial protein turnover via the ubiquitin proteasome system to limit mitochondrial stress and inflammation. Cell Rep 43, 114780.","journal-title":"Cell Rep"},{"key":"3389_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s12276-025-01455-8","volume":"57","author":"L Yi","year":"2025","unstructured":"Yi, L., Li, J., He, Y., Wang, J., Wang, M., Guo, S., Luo, M., Wu, B., Xu, M., Tian, Q., et al. (2025). ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer\u2019s disease. Exp Mol Med 57, 1032\u20131046.","journal-title":"Exp Mol Med"},{"key":"3389_CR32","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41467-025-67877-0","volume":"17","author":"G Zang","year":"2025","unstructured":"Zang, G., Xu, S., Sun, Z., Zhang, L., Qian, Y., Yao, H., Li, L., and Wang, Z. (2025). IDH2 lactylation promotes angiogenesis in murine diabetic myocardial infarction via blocking Cav1-eNOS interaction. Nat Commun 17, 1117.","journal-title":"Nat Commun"},{"key":"3389_CR33","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s11427-024-2861-9","volume":"68","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Qi, M., and Fu, Q. (2025). Molecular genetics of congenital heart disease. Sci China Life Sci 68, 2225\u20132242.","journal-title":"Sci China Life Sci"},{"key":"3389_CR34","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41467-022-29060-7","volume":"13","author":"M Zhao","year":"2022","unstructured":"Zhao, M., Wei, H., Li, C., Zhan, R., Liu, C., Gao, J., Yi, Y., Cui, X., Shan, W., Ji, L., et al. (2022). Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy. Nat Commun 13, 1757.","journal-title":"Nat Commun"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-026-3389-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:04:09Z","timestamp":1790633049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-026-3389-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":34,"alternative-id":["3389"],"URL":"https:\/\/doi.org\/10.1007\/s11427-026-3389-1","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. The population study was approved by the Ethics Committee of Peking University (Approval No. IRB00001052-11068) and conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice, and all animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of Peking University (Approval Nos. LA2021536, LA2021513).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}